Molecular mechanisms of nervous system tumors
Molecular mechanisms of nervous system tumors
Our laboratory, the Neurosurgical Unit for Pituitary and Inheritable Diseases, studies how tumors of the central and peripheral nervous system arise, persist, and respond to therapy. We focus on two groups of tumors: 1. pituitary neuroendocrine tumors, including corticotroph tumors that cause Cushing’s disease, and 2. tumors associated with inheritable tumor predisposition syndromes such as NF2-related schwannomatosis, and von Hippel-Lindau disease (VHL). These conditions share a common question: how specific genetic and epigenetic changes reprogram cell signaling, stress responses, and cell identity to drive tumor growth.
As a neurosurgical program at the NIH Clinical Center, we have direct access to fresh, surgically sourced human tumor tissue linked to detailed clinical, imaging, and germline genetic data from large natural history cohorts. Students use this material to generate hypotheses through multi-omic approaches, including single-cell and spatial transcriptomics, chromatin accessibility, DNA methylation, whole-genome sequencing, and proteomics/phosphoproteomics, combined with computational analysis on NIH high-performance computing. Candidate mechanisms are then tested in the wet lab using patient-derived cultures, hiPSC-derived organoids, and engineered cell models, with tools such as CRISPR and degron-based protein depletion, targeted epigenome editing, signaling and drug-response assays, and structural modeling.
Current areas of interest include integrated stress response signaling and translational control nervous system tumors, and the role of merlin gene dosage in NF2-related tumors. Findings from the laboratory feed directly into window-of-opportunity clinical studies conducted within the group, giving students a clear path from patient samples to mechanism to therapy. A UK partner laboratory in cancer biology, signaling, epigenomics, glial or neuroendocrine biology, or computational genomics would be an excellent complement.

